'Covering the tail' after stopping efavirenz-based antiretroviral therapy.
作者信息
Maartens Gary
机构信息
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
出版信息
South Afr J HIV Med. 2020 Jan 27;21(1):1036. doi: 10.4102/sajhivmed.v21i1.1036. eCollection 2020.
Abstract
摘要
相似文献
1
'Covering the tail' after stopping efavirenz-based antiretroviral therapy.停用基于依非韦伦的抗逆转录病毒治疗后的“遮盖尾巴”
South Afr J HIV Med. 2020 Jan 27;21(1):1036. doi: 10.4102/sajhivmed.v21i1.1036. eCollection 2020.
2
Antiretroviral drugs for prevention of mother-to-child transmission: pharmacologic considerations for a public health approach.用于预防母婴传播的抗逆转录病毒药物：公共卫生方法的药理学考量
AIDS. 2014 Nov 13;28(17):2551-63. doi: 10.1097/QAD.0000000000000439.
3
Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.使用“燕尾征”和壳核低信号作为生物标志物区分多系统萎缩与特发性帕金森病：一项磁敏感加权成像研究
Eur Radiol. 2017 Aug;27(8):3174-3180. doi: 10.1007/s00330-017-4743-x. Epub 2017 Jan 19.
4
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.基于奈韦拉平和依非韦伦的抗逆转录病毒疗法与基于利福平的抗结核疗法联合使用时的疗效。
JAMA. 2008 Aug 6;300(5):530-9. doi: 10.1001/jama.300.5.530.
5
Comparison of the effectiveness of initial combined antiretroviral therapy with nelfinavir or efavirenz at a university-based outpatient service in Brazil.在巴西一家大学门诊服务机构中，奈非那韦与依非韦伦初始联合抗逆转录病毒疗法的疗效比较。
Braz J Med Biol Res. 2007 Jul;40(7):963-9. doi: 10.1590/s0100-879x2007000700011.
6
Treatment Outcomes of Nevirapine- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Antiretroviral-Naive Adult Patients in Ethiopia: A Cohort Study.埃塞俄比亚未接受过抗逆转录病毒治疗的成年患者中，基于奈韦拉平与依非韦伦的高效抗逆转录病毒治疗方案的治疗结果：一项队列研究
Ther Innov Regul Sci. 2015 May;49(3):443-449. doi: 10.1177/2168479014565472.
7
Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.初治HIV感染患者中基于依非韦伦的治疗方案：随机对照试验的系统评价和荟萃分析
PLoS One. 2015 May 1;10(5):e0124279. doi: 10.1371/journal.pone.0124279. eCollection 2015.
8
A 33-year-old patient with human immunodeficiency virus on antiretroviral therapy with efavirenz-induced complex partial seizures: a case report.一名33岁接受抗逆转录病毒治疗且服用依非韦伦诱发复杂部分性癫痫的人类免疫缺陷病毒患者：病例报告。
J Med Case Rep. 2016 Apr 13;10:93. doi: 10.1186/s13256-016-0876-9.
9
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.对感染艾滋病毒且患有结核病患者中利福布汀与依非韦伦之间药物相互作用的评估。
Clin Infect Dis. 2005 Nov 1;41(9):1343-9. doi: 10.1086/496980. Epub 2005 Sep 29.
10
Has the time come to abandon efavirenz for first-line antiretroviral therapy?是时候放弃依非韦伦用于一线抗逆转录病毒治疗了吗？
J Antimicrob Chemother. 2014 Jul;69(7):1742-7. doi: 10.1093/jac/dku058. Epub 2014 Mar 5.
引用本文的文献
1
Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update.南部非洲艾滋病毒临床医生协会成人抗逆转录病毒治疗指南：2020年更新版
South Afr J HIV Med. 2020 Sep 16;21(1):1115. doi: 10.4102/sajhivmed.v21i1.1115. eCollection 2020.
本文引用的文献
1
Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy.孕期开始的基于依非韦伦的抗逆转录病毒治疗停药后的耐药性。
South Afr J HIV Med. 2020 Jan 27;21(1):1023. doi: 10.4102/sajhivmed.v21i1.1023. eCollection 2020.
2
Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.简短报告：HIV治疗中断试验中病毒载量结果之间的关系
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):310-3. doi: 10.1097/QAI.0000000000000964.
3
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.所表达的HIV储存库的大小可预测治疗中断后病毒反弹的时间。
AIDS. 2016 Jan 28;30(3):343-53. doi: 10.1097/QAD.0000000000000953.
4
Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.南非成人和儿童HIV感染者血浆依法韦仑暴露的药物遗传学
Br J Clin Pharmacol. 2015 Jul;80(1):146-56. doi: 10.1111/bcp.12590. Epub 2015 May 28.
5
Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and prevention.停止药物摄入后，替诺福韦、恩曲他滨的细胞内和血浆浓度以及依非韦伦的血浆浓度下降：对 HIV 治疗和预防的影响。
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):275-81. doi: 10.1097/QAI.0b013e3182829bd0.
6
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.短程 AZT 加 3TC 降低奈韦拉平耐药性预防母婴 HIV 传播的疗效：一项随机临床试验。
PLoS Med. 2009 Oct;6(10):e1000172. doi: 10.1371/journal.pmed.1000172. Epub 2009 Oct 27.
7
Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.单剂量替诺福韦和恩曲他滨用于降低接受产时奈韦拉平预防围产期HIV感染的女性对非核苷类逆转录酶抑制剂药物的病毒耐药性：一项开放标签随机试验。
Lancet. 2007 Nov 17;370(9600):1698-705. doi: 10.1016/S0140-6736(07)61605-5. Epub 2007 Nov 7.
Zotero 插件